SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-303052
Filing Date
2018-10-19
Accepted
2018-10-19 16:13:07
Documents
12
Period of Report
2018-10-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d640111d8k.htm 8-K 17604
2 EX-99.1 d640111dex991.htm EX-99.1 44942
3 GRAPHIC g640111g1019091744564.jpg GRAPHIC 18121
4 GRAPHIC g640111g1019091744673.jpg GRAPHIC 20160
5 GRAPHIC g640111g1019091744782.jpg GRAPHIC 23900
6 GRAPHIC g640111g1019091744891.jpg GRAPHIC 15978
7 GRAPHIC g640111g1019091745000.jpg GRAPHIC 21684
8 GRAPHIC g640111g1019091745094.jpg GRAPHIC 12452
9 GRAPHIC g640111g1019091745219.jpg GRAPHIC 22629
10 GRAPHIC g640111g1019091745344.jpg GRAPHIC 41115
11 GRAPHIC g640111g1019091745468.jpg GRAPHIC 35247
12 GRAPHIC g640111g1019091745593.jpg GRAPHIC 33620
  Complete submission text file 0001193125-18-303052.txt   402548
Mailing Address 500 TOTTEN POND ROAD WALTHAM MA 02451
Business Address 500 TOTTEN POND ROAD WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Filer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38219 | Film No.: 181130577
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1